The Comparative Clinical Performance of Four SARS-CoV-2 Rapid Antigen Tests and Their Correlation to Infectivity In Vitro.
The Comparative Clinical Performance of Four SARS-CoV-2 Rapid Antigen Tests and Their Correlation to Infectivity In Vitro.
复制标题
DOI:
10.3390/jcm10020328
复制
发表时间:
2021-01-17
影响因子:
3.9
通讯作者:
Rabenau HF
中科院分区:
文献类型:
--
作者:
Kohmer N;Toptan T;Pallas C;Karaca O;Pfeiffer A;Westhaus S;Widera M;Berger A;Hoehl S;Kammel M;Ciesek S;Rabenau HF
Due to globally rising numbers of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) infections, resources for real-time reverse-transcription polymerase chain reaction (rRT-PCR)-based testing have been exhausted. In order to meet the demands of testing and reduce transmission, SARS-CoV-2 antigen-detecting rapid diagnostic tests (Ag-RDTs) are being considered. These tests are fast, inexpensive, and simple to use, but whether they detect potentially infectious cases has not been well studied. We evaluated three lateral flow assays (RIDA®QUICK SARS-CoV-2 Antigen (R-Biopharm), SARS-CoV-2 Rapid Antigen Test (Roche)), and NADAL® COVID-19 Ag Test (Nal von Minden GmbH, Regensburg, Germany) and one microfluidic immunofluorescence assay (SARS-CoV-2 Ag Test (LumiraDx GmbH, Cologne, Germany)) using 100 clinical samples. Diagnostic rRT-PCR and cell culture testing as a marker for infectivity were performed in parallel. The overall Ag-RDT sensitivity for rRT-PCR-positive samples ranged from 24.3% to 50%. However, for samples with a viral load of more than 6 log10 RNA copies/mL (22/100), typically seen in infectious individuals, Ag-RDT positivity was between 81.8% and 100%. Only 51.6% (33/64) of the rRT-PCR-positive samples were infectious in cell culture. In contrast, three Ag-RDTs demonstrated a more significant correlation with cell culture infectivity (61.8–82.4%). Our findings suggest that large-scale SARS-CoV-2 Ag-RDT-based testing can be considered for detecting potentially infective individuals and reducing the virus spread.
登录
查看更多内容
影响因子:
11.8
作者:
Perera RAPM;Tso E;Tsang OTY;Tsang DNC;Fung K;Leung YWY;Chin AWH;Chu DKW;Cheng SMS;Poon LLM;Chuang VWM;Peiris M
通讯作者:
Peiris M
影响因子:
5.6
作者:
Toptan, Tuna;Hoehl, Sebastian;Widera, Marek
通讯作者:
Widera, Marek
DOI:
10.1007/s10096-020-03913-9
发表时间:
2020-04-27
影响因子:
4.5
作者:
La Scola, Bernard;Le Bideau, Marion;Raoult, Didier
通讯作者:
Raoult, Didier
影响因子:
1.9
作者:
LANDIS, JR;KOCH, GG
通讯作者:
KOCH, GG
DOI:
10.1001/jama.2020.21694
发表时间:
2020-12-01
期刊:
JAMA
影响因子:
--
作者:
Manabe YC;Sharfstein JS;Armstrong K
通讯作者:
Armstrong K